Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Operating Expenses | 6,666 | 1,385 | -8,901 | 1,617 | 932 |
| Operating Income | -6,666 | -1,385 | 8,901 | -1,617 | -932 |
| Other Income | 4 | 11 | -93 | -418 | -70 |
| Pre-tax Income | -6,662 | -1,374 | 8,808 | -2,035 | -1,002 |
| Net Income Continuous | -6,662 | -1,374 | 8,808 | -2,035 | -1,002 |
| Net Income | $-6,662 | $-1,374 | $8,808 | $-2,035 | $-1,002 |
| EPS Basic Total Ops | -23.74 | -10.61 | 157.02 | -78.24 | -40.47 |
| EPS Basic Continuous Ops | -28.84 | -59.69 | 499.10 | -451.86 | -231.05 |
| EPS Diluted Total Ops | -23.74 | -10.61 | 157.02 | -78.24 | -40.47 |
| EPS Diluted Continuous Ops | -28.84 | -59.69 | 499.10 | -451.86 | -231.05 |
| EBITDA(a) | $-6,654 | $-1,381 | $8,920 | $-1,621 | $-1,002 |